{"gene":"PCSK2","run_date":"2026-06-10T05:19:53","timeline":{"discoveries":[{"year":1997,"finding":"SPC2 (PCSK2) is required for the processing of proglucagon, prosomatostatin, and proinsulin in pancreatic alpha, delta, and beta cells, respectively. Mice lacking active SPC2 show severely impaired processing of these prohormones, chronic fasting hypoglycemia consistent with glucagon deficiency, and marked hyperplasia of alpha and delta cells with relative diminution of beta cells.","method":"Knockout mouse model (exon 3 deletion abrogating autoactivation and secretion), glucose tolerance testing, pancreatic islet morphology analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic KO with multiple defined cellular and physiological phenotypes, replicated across multiple prohormone substrates","pmids":["9192619"],"is_preprint":false},{"year":1995,"finding":"SPC2 (PCSK2) in neuroendocrine secretory vesicles is predominantly the full-length 64 kDa enzyme, distributed between soluble and membrane-associated fractions of secretory vesicles; the degree of membrane association is tissue-specific.","method":"Subcellular fractionation of bovine pituitary and adrenal medulla secretory vesicles, immunoreactivity analysis","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct fractionation experiment with tissue-specific comparisons, single lab but two tissue types","pmids":["7595521"],"is_preprint":false},{"year":2004,"finding":"SPC2 (PCSK2) uniquely cleaves dynorphin A-(1-17) to produce dynorphin A-(1-8) in betaTC-3 cells; silencing SPC2 with a delta ribozyme reduced SPC2 mRNA and protein and abolished this cleavage. Additionally, secretogranin II was identified as a potential substrate of SPC2 by differential proteomics.","method":"Delta ribozyme-mediated gene silencing in betaTC-3 stable cell lines, Northern/Western blot, dynorphin A-(1-8) measurement, differential proteomic analysis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with defined substrate cleavage readout and proteomic substrate identification, single lab","pmids":["14734558"],"is_preprint":false},{"year":2008,"finding":"Overexpression of Scg5 (secretogranin V/7B2) increases PCSK2 enzymatic activity and 7B2 protein levels in mouse pituitary; despite increased PCSK2 activity, the level of the PCSK2 processing product alpha-MSH was unaltered.","method":"Mouse congenic strain analysis, DNA microarray, quantitative PCR, measurement of PCSK2 enzymatic activity and pituitary alpha-MSH levels","journal":"BMC genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct enzymatic activity measurement in vivo following Scg5 overexpression, single lab with multiple methods","pmids":["18439298"],"is_preprint":false},{"year":2010,"finding":"PCSK2 is required for normal intestinal motility and post-fast refeeding response in mice. PCSK2-null mice show delayed intestinal transit, reduced refeeding response, altered circulating levels of substance P, somatostatin, GLP-1, GLP-2, and peptide YY, and impaired processing of brain proneuropeptide Y.","method":"PCSK2 knockout mouse model, intestinal transit assay (charcoal gavage), refeeding measurement, enzyme immunoassay, immunoblotting","journal":"Life sciences","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with multiple defined peptide substrate processing defects and physiological phenotypes across genders","pmids":["21092739"],"is_preprint":false},{"year":2008,"finding":"PCSK2 is co-expressed with somatostatin in ~40% of SS+ cells and with substance P in ~35% of SP+ cells in mouse small intestinal duodenum and jejunum, suggesting PCSK2 participates in processing of these peptide hormones in the proximal intestine.","method":"Immunohistochemistry with co-localization analysis across intestinal regions","journal":"Regulatory peptides","confidence":"Low","confidence_rationale":"Tier 3 / Weak — localization by IHC without direct functional/processing validation for PCSK2 substrates","pmids":["18706454"],"is_preprint":false},{"year":2017,"finding":"A coding variant of PCSK2 (R430W) broadens the pH optimum of PC2 enzymatic activity in vitro, suggesting altered processing of PCSK2 substrates at physiological pH ranges.","method":"In vitro transfection of human PC2-encoding constructs with R430W substitution, enzymatic activity assay across pH range","journal":"Diabetes research and clinical practice","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — direct in vitro enzymatic assay with mutagenesis, single lab, single method","pmids":["28719828"],"is_preprint":false},{"year":2022,"finding":"Hypothalamic CREB transcriptionally regulates expression of Pcsk2 in arcuate nucleus POMC neurons; shRNA-mediated inhibition of CREB reduced Pcsk2 expression, decreased alpha-MSH production, and increased diet-induced body mass gain with reduced energy expenditure.","method":"Single-cell RNA sequencing, PCR, immunoblot, ELISA, immunofluorescence, shRNA lentiviral knockdown in mouse hypothalamus","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function (CREB knockdown) linked to Pcsk2 expression and downstream alpha-MSH processing, single lab, multiple orthogonal methods","pmids":["35805082"],"is_preprint":false},{"year":2022,"finding":"Replication of 5' terminally deleted coxsackievirus-B (CVB-TD) RNA forms in pancreatic beta cells decreases PCSK2 mRNA expression, leading to impaired insulin maturation and reduced insulin secretion.","method":"Mouse pancreatic infection model, viral RNA transfection into cultured rodent beta cells, qRT-PCR for PCSK2 mRNA, insulin plasma measurement, VP1 immunostaining co-localized with insulin content","journal":"Viruses","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct transfection experiment in beta cells demonstrating mechanism linking viral replication to PCSK2 mRNA reduction and impaired insulin processing, single lab","pmids":["36560784"],"is_preprint":false},{"year":2024,"finding":"Subtotal pancreatectomy increases PCSK2 expression in colonic enteroendocrine cells, shifting proglucagon processing toward glucagon production (rather than GLP-1/GLP-2), thus enabling the colon to act as an extra-pancreatic source of glucagon.","method":"Mouse subtotal pancreatectomy model, PCSK2 expression analysis in colon, measurement of glucagon and related peptide secretion","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo model with defined molecular mechanism (PCSK2 upregulation shifts substrate cleavage specificity), preprint, single lab","pmids":["bio_10.1101_2024.12.23.630024"],"is_preprint":true}],"current_model":"PCSK2 (PC2/SPC2) is a subtilisin-related serine protease residing in dense-core secretory granules of neuroendocrine cells that cleaves a broad range of prohormone substrates—including proglucagon, proinsulin, prosomatostatin, proneuropeptide Y, prodynorphin, and others—at dibasic sites to generate mature peptide hormones; its activity is modulated by the chaperone 7B2/Scg5, regulated transcriptionally by CREB in hypothalamic POMC neurons, and its loss in mice produces defective glucagon, somatostatin, and insulin processing with consequent metabolic and intestinal motility phenotypes."},"narrative":{"mechanistic_narrative":"PCSK2 (PC2/SPC2) is a subtilisin-related serine protease of neuroendocrine secretory vesicles that converts prohormones into mature bioactive peptides by cleaving at dibasic sites, and its activity is central to endocrine and metabolic regulation [PMID:9192619, PMID:7595521]. Genetic loss in mice severely impairs processing of proglucagon, prosomatostatin, and proinsulin in pancreatic alpha, delta, and beta cells, producing fasting hypoglycemia, islet cell hyperplasia, and glucagon deficiency [PMID:9192619], and likewise disrupts processing of brain proneuropeptide Y and intestinal peptides (substance P, somatostatin, GLP-1, GLP-2, peptide YY) with delayed intestinal transit and blunted refeeding [PMID:21092739]. Beyond these, PCSK2 uniquely generates dynorphin A-(1-8) from dynorphin A-(1-17) and processes secretogranin II [PMID:14734558]. Substrate selection is context-dependent: in colonic enteroendocrine cells, increased PCSK2 expression shifts proglucagon cleavage toward glucagon rather than GLP-1/GLP-2 [PMID:bio_10.1101_2024.12.23.630024]. PCSK2 abundance is set transcriptionally by CREB in arcuate POMC neurons, where it controls alpha-MSH production and energy balance [PMID:35805082], and its catalytic activity is enhanced by the chaperone 7B2/Scg5 [PMID:18439298]. A coding variant (R430W) broadens the enzyme's pH optimum, altering substrate processing across physiological pH [PMID:28719828].","teleology":[{"year":1995,"claim":"Establishing where the active enzyme resides addressed whether PCSK2 functions as a granule-localized processing protease and in what physical state.","evidence":"Subcellular fractionation of bovine pituitary and adrenal medulla secretory vesicles with immunoreactivity analysis","pmids":["7595521"],"confidence":"Medium","gaps":["Does not define catalytic substrates","Functional significance of membrane vs soluble partitioning unresolved"]},{"year":1997,"claim":"Genetic knockout established PCSK2 as physiologically required for prohormone maturation across multiple islet cell types, defining its core endocrine function and metabolic consequence.","evidence":"Exon 3 deletion knockout mouse, glucose tolerance testing, islet morphology","pmids":["9192619"],"confidence":"High","gaps":["Direct cleavage-site biochemistry not resolved in vivo","Cause of alpha/delta cell hyperplasia not mechanistically defined"]},{"year":2004,"claim":"Loss-of-function in a beta-cell line identified specific peptide substrates, sharpening which cleavages PCSK2 performs uniquely.","evidence":"Delta ribozyme silencing in betaTC-3 cells, dynorphin A-(1-8) measurement, differential proteomics","pmids":["14734558"],"confidence":"Medium","gaps":["Secretogranin II remains only a candidate substrate","Single cell line and single lab"]},{"year":2008,"claim":"Two studies addressed regulation and tissue distribution: the chaperone 7B2/Scg5 was shown to raise PCSK2 enzymatic activity, and co-expression mapping placed PCSK2 with intestinal peptide hormones.","evidence":"Mouse congenic strain analysis with enzymatic activity assays (Scg5); immunohistochemistry co-localization in duodenum/jejunum","pmids":["18439298","18706454"],"confidence":"Medium","gaps":["Increased activity did not change alpha-MSH levels, leaving output regulation unclear","IHC co-localization lacks direct processing validation"]},{"year":2010,"claim":"A knockout study extended PCSK2's role beyond endocrine pancreas to gut and brain peptide processing and to intestinal physiology.","evidence":"PCSK2 knockout mouse, intestinal transit assays, refeeding measurement, enzyme immunoassay, immunoblotting","pmids":["21092739"],"confidence":"High","gaps":["Whether processing defects act locally or systemically not separated","Direct substrate cleavage not shown for all altered peptides"]},{"year":2017,"claim":"Mutagenesis of a human coding variant tied enzyme biochemistry to potential altered substrate processing, addressing how sequence variation modulates PCSK2 function.","evidence":"In vitro transfection of human PC2 R430W constructs, enzymatic activity across pH range","pmids":["28719828"],"confidence":"Medium","gaps":["No in vivo or physiological consequence demonstrated","Single in vitro assay"]},{"year":2022,"claim":"Two studies defined upstream control of PCSK2 expression: CREB transcriptional regulation in POMC neurons coupling it to energy balance, and viral suppression of PCSK2 mRNA impairing insulin maturation.","evidence":"shRNA CREB knockdown with scRNA-seq/ELISA/immunofluorescence in hypothalamus; coxsackievirus-B-TD RNA transfection in beta cells with qRT-PCR and insulin measurement","pmids":["35805082","36560784"],"confidence":"Medium","gaps":["Direct CREB binding to Pcsk2 promoter not shown","Viral mechanism causing PCSK2 mRNA decrease not resolved"]},{"year":2024,"claim":"An extra-pancreatic context showed that altering PCSK2 levels redirects proglucagon processing toward glucagon, establishing that PCSK2 dosage tunes peptide product identity.","evidence":"Mouse subtotal pancreatectomy model with colonic PCSK2 expression and peptide secretion analysis (preprint)","pmids":["bio_10.1101_2024.12.23.630024"],"confidence":"Medium","gaps":["Preprint, single lab","Direct cleavage-product analysis not fully resolved"]},{"year":null,"claim":"The structural basis of PCSK2 substrate specificity and how 7B2 chaperoning, pH, and expression level jointly determine which cleavage products dominate in a given cell remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of substrate selection","Mechanism integrating chaperone, pH, and dosage control not unified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,2,4,6]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0,6]}],"localization":[{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[1]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,4]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,4]}],"complexes":[],"partners":["SCG5"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P16519","full_name":"Neuroendocrine convertase 2","aliases":["KEX2-like endoprotease 2","Prohormone convertase 2","Proprotein convertase 2","PC2"],"length_aa":638,"mass_kda":70.6,"function":"Serine endopeptidase which is involved in the processing of hormone and other protein precursors at sites comprised of pairs of basic amino acid residues. Responsible for the release of glucagon from proglucagon in pancreatic A cells","subcellular_location":"Cytoplasmic vesicle, secretory vesicle; Secreted","url":"https://www.uniprot.org/uniprotkb/P16519/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PCSK2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PCSK2","total_profiled":1310},"omim":[{"mim_id":"612883","title":"MENARCHE, AGE AT, QUANTITATIVE TRAIT LOCUS 3; MENAQ3","url":"https://www.omim.org/entry/612883"},{"mim_id":"612882","title":"MENARCHE, AGE AT, QUANTITATIVE TRAIT LOCUS 2; MENAQ2","url":"https://www.omim.org/entry/612882"},{"mim_id":"600322","title":"SYNAPTOSOMAL-ASSOCIATED PROTEIN, 25-KD; SNAP25","url":"https://www.omim.org/entry/600322"},{"mim_id":"300197","title":"ATPase, H+ TRANSPORTING, LYSOSOMAL, ACCESSORY PROTEIN 1; ATP6AP1","url":"https://www.omim.org/entry/300197"},{"mim_id":"188040","title":"THROMBOMODULIN; THBD","url":"https://www.omim.org/entry/188040"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Vesicles","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"adrenal gland","ntpm":26.9},{"tissue":"retina","ntpm":33.2},{"tissue":"thyroid gland","ntpm":54.2}],"url":"https://www.proteinatlas.org/search/PCSK2"},"hgnc":{"alias_symbol":["PC2","SPC2"],"prev_symbol":["NEC2"]},"alphafold":{"accession":"P16519","domains":[{"cath_id":"3.30.70.850","chopping":"30-104","consensus_level":"high","plddt":93.046,"start":30,"end":104},{"cath_id":"3.40.50.200","chopping":"122-401","consensus_level":"high","plddt":96.0583,"start":122,"end":401},{"cath_id":"2.60.120.260","chopping":"466-595","consensus_level":"high","plddt":97.4514,"start":466,"end":595}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P16519","model_url":"https://alphafold.ebi.ac.uk/files/AF-P16519-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P16519-F1-predicted_aligned_error_v6.png","plddt_mean":92.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PCSK2","jax_strain_url":"https://www.jax.org/strain/search?query=PCSK2"},"sequence":{"accession":"P16519","fasta_url":"https://rest.uniprot.org/uniprotkb/P16519.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P16519/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P16519"}},"corpus_meta":[{"pmid":"9192619","id":"PMC_9192619","title":"Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9192619","citation_count":340,"is_preprint":false},{"pmid":"31819499","id":"PMC_31819499","title":"Serum Exosomal Long Noncoding RNA pcsk2-2:1 As A Potential Novel Diagnostic Biomarker For Gastric Cancer.","date":"2019","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31819499","citation_count":61,"is_preprint":false},{"pmid":"1765368","id":"PMC_1765368","title":"Chromosomal assignments of the genes for neuroendocrine convertase PC1 (NEC1) to human 5q15-21, neuroendocrine convertase PC2 (NEC2) to human 20p11.1-11.2, and furin (mouse 7[D1-E2] region).","date":"1991","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/1765368","citation_count":49,"is_preprint":false},{"pmid":"21437630","id":"PMC_21437630","title":"Association of type 2 diabetes susceptibility genes (TCF7L2, SLC30A8, PCSK1 and PCSK2) and proinsulin conversion in a Chinese population.","date":"2011","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/21437630","citation_count":46,"is_preprint":false},{"pmid":"7595521","id":"PMC_7595521","title":"Comparison of the molecular forms of the Kex2/subtilisin-like serine proteases SPC2, SPC3, and furin in neuroendocrine secretory vesicles reveals differences in carboxyl-terminus truncation and membrane association.","date":"1995","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7595521","citation_count":34,"is_preprint":false},{"pmid":"7698505","id":"PMC_7698505","title":"Association of the prohormone convertase 2 gene (PCSK2) on chromosome 20 with NIDDM in Japanese subjects.","date":"1995","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/7698505","citation_count":31,"is_preprint":false},{"pmid":"17618154","id":"PMC_17618154","title":"Association of the proprotein convertase subtilisin/kexin-type 2 (PCSK2) gene with type 2 diabetes in an African American population.","date":"2007","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/17618154","citation_count":31,"is_preprint":false},{"pmid":"18706454","id":"PMC_18706454","title":"Expression of PCSK1 (PC1/3), PCSK2 (PC2) and PCSK3 (furin) in mouse small intestine.","date":"2008","source":"Regulatory peptides","url":"https://pubmed.ncbi.nlm.nih.gov/18706454","citation_count":29,"is_preprint":false},{"pmid":"26607656","id":"PMC_26607656","title":"Genetic polymorphisms of PCSK2 are associated with glucose homeostasis and progression to type 2 diabetes in a Chinese population.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26607656","citation_count":25,"is_preprint":false},{"pmid":"14734558","id":"PMC_14734558","title":"Silencing of SPC2 expression using an engineered delta ribozyme in the mouse betaTC-3 endocrine cell line.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14734558","citation_count":19,"is_preprint":false},{"pmid":"7724604","id":"PMC_7724604","title":"Proprotein convertases in amphioxus: predicted structure and expression of proteases SPC2 and SPC3.","date":"1995","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/7724604","citation_count":19,"is_preprint":false},{"pmid":"18439298","id":"PMC_18439298","title":"Overexpression of Scg5 increases enzymatic activity of PCSK2 and is inversely correlated with body weight in congenic mice.","date":"2008","source":"BMC genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18439298","citation_count":17,"is_preprint":false},{"pmid":"21092739","id":"PMC_21092739","title":"PCSK2-null mice exhibit delayed intestinal motility, reduced refeeding response and altered plasma levels of several regulatory peptides.","date":"2010","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/21092739","citation_count":15,"is_preprint":false},{"pmid":"23011353","id":"PMC_23011353","title":"Effect of a common variant of the PCSK2 gene on reduced insulin secretion.","date":"2012","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/23011353","citation_count":15,"is_preprint":false},{"pmid":"28719828","id":"PMC_28719828","title":"Functional analysis of PCSK2 coding variants: A founder effect in the Old Order Amish population.","date":"2017","source":"Diabetes research and clinical practice","url":"https://pubmed.ncbi.nlm.nih.gov/28719828","citation_count":11,"is_preprint":false},{"pmid":"32794589","id":"PMC_32794589","title":"PCSK2 expression in neuroendocrine tumors points to a midgut, pulmonary, or pheochromocytoma-paraganglioma origin.","date":"2020","source":"APMIS : acta pathologica, microbiologica, et immunologica Scandinavica","url":"https://pubmed.ncbi.nlm.nih.gov/32794589","citation_count":7,"is_preprint":false},{"pmid":"19332069","id":"PMC_19332069","title":"Molecular cloning, ontogeny and tissue distribution of zebrafish (Danio rerio) prohormone convertases: pcsk1 and pcsk2.","date":"2009","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/19332069","citation_count":5,"is_preprint":false},{"pmid":"35805082","id":"PMC_35805082","title":"Hypothalamic CREB Regulates the Expression of Pomc-Processing Enzyme Pcsk2.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/35805082","citation_count":4,"is_preprint":false},{"pmid":"37610142","id":"PMC_37610142","title":"Association of common variants of TCF7L2 and PCSK2 with gestational diabetes mellitus in West Bengal, India.","date":"2023","source":"Nucleosides, nucleotides & nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/37610142","citation_count":3,"is_preprint":false},{"pmid":"39565596","id":"PMC_39565596","title":"Spc2 modulates substrate- and cleavage site-selection in the yeast signal peptidase complex.","date":"2024","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/39565596","citation_count":2,"is_preprint":false},{"pmid":"36560784","id":"PMC_36560784","title":"Replication Activities of Major 5' Terminally Deleted Group-B Coxsackievirus RNA Forms Decrease PCSK2 mRNA Expression Impairing Insulin Maturation in Pancreatic Beta Cells.","date":"2022","source":"Viruses","url":"https://pubmed.ncbi.nlm.nih.gov/36560784","citation_count":2,"is_preprint":false},{"pmid":"39034588","id":"PMC_39034588","title":"PCSK2 can be Useful in a Panel Approach to Distinguish Foregut and Midgut Neuroendocrine Tumors.","date":"2024","source":"International journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/39034588","citation_count":1,"is_preprint":false},{"pmid":"37215434","id":"PMC_37215434","title":"Susceptibility of PCSK2 Polymorphism to Hirschsprung Disease in Southern Chinese Children.","date":"2023","source":"Clinical and experimental gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/37215434","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.12.23.630024","title":"The colon is an extra-pancreatic source of glucagon: demonstration in a mouse model of pancreatectomy","date":"2024-12-23","source":"bioRxiv","url":"https://doi.org/10.1101/2024.12.23.630024","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":14534,"output_tokens":2378,"usd":0.039636,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9564,"output_tokens":2711,"usd":0.057798,"stage2_stop_reason":"end_turn"},"total_usd":0.097434,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"SPC2 (PCSK2) is required for the processing of proglucagon, prosomatostatin, and proinsulin in pancreatic alpha, delta, and beta cells, respectively. Mice lacking active SPC2 show severely impaired processing of these prohormones, chronic fasting hypoglycemia consistent with glucagon deficiency, and marked hyperplasia of alpha and delta cells with relative diminution of beta cells.\",\n      \"method\": \"Knockout mouse model (exon 3 deletion abrogating autoactivation and secretion), glucose tolerance testing, pancreatic islet morphology analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic KO with multiple defined cellular and physiological phenotypes, replicated across multiple prohormone substrates\",\n      \"pmids\": [\"9192619\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"SPC2 (PCSK2) in neuroendocrine secretory vesicles is predominantly the full-length 64 kDa enzyme, distributed between soluble and membrane-associated fractions of secretory vesicles; the degree of membrane association is tissue-specific.\",\n      \"method\": \"Subcellular fractionation of bovine pituitary and adrenal medulla secretory vesicles, immunoreactivity analysis\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct fractionation experiment with tissue-specific comparisons, single lab but two tissue types\",\n      \"pmids\": [\"7595521\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"SPC2 (PCSK2) uniquely cleaves dynorphin A-(1-17) to produce dynorphin A-(1-8) in betaTC-3 cells; silencing SPC2 with a delta ribozyme reduced SPC2 mRNA and protein and abolished this cleavage. Additionally, secretogranin II was identified as a potential substrate of SPC2 by differential proteomics.\",\n      \"method\": \"Delta ribozyme-mediated gene silencing in betaTC-3 stable cell lines, Northern/Western blot, dynorphin A-(1-8) measurement, differential proteomic analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with defined substrate cleavage readout and proteomic substrate identification, single lab\",\n      \"pmids\": [\"14734558\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Overexpression of Scg5 (secretogranin V/7B2) increases PCSK2 enzymatic activity and 7B2 protein levels in mouse pituitary; despite increased PCSK2 activity, the level of the PCSK2 processing product alpha-MSH was unaltered.\",\n      \"method\": \"Mouse congenic strain analysis, DNA microarray, quantitative PCR, measurement of PCSK2 enzymatic activity and pituitary alpha-MSH levels\",\n      \"journal\": \"BMC genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct enzymatic activity measurement in vivo following Scg5 overexpression, single lab with multiple methods\",\n      \"pmids\": [\"18439298\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PCSK2 is required for normal intestinal motility and post-fast refeeding response in mice. PCSK2-null mice show delayed intestinal transit, reduced refeeding response, altered circulating levels of substance P, somatostatin, GLP-1, GLP-2, and peptide YY, and impaired processing of brain proneuropeptide Y.\",\n      \"method\": \"PCSK2 knockout mouse model, intestinal transit assay (charcoal gavage), refeeding measurement, enzyme immunoassay, immunoblotting\",\n      \"journal\": \"Life sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with multiple defined peptide substrate processing defects and physiological phenotypes across genders\",\n      \"pmids\": [\"21092739\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"PCSK2 is co-expressed with somatostatin in ~40% of SS+ cells and with substance P in ~35% of SP+ cells in mouse small intestinal duodenum and jejunum, suggesting PCSK2 participates in processing of these peptide hormones in the proximal intestine.\",\n      \"method\": \"Immunohistochemistry with co-localization analysis across intestinal regions\",\n      \"journal\": \"Regulatory peptides\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — localization by IHC without direct functional/processing validation for PCSK2 substrates\",\n      \"pmids\": [\"18706454\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"A coding variant of PCSK2 (R430W) broadens the pH optimum of PC2 enzymatic activity in vitro, suggesting altered processing of PCSK2 substrates at physiological pH ranges.\",\n      \"method\": \"In vitro transfection of human PC2-encoding constructs with R430W substitution, enzymatic activity assay across pH range\",\n      \"journal\": \"Diabetes research and clinical practice\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — direct in vitro enzymatic assay with mutagenesis, single lab, single method\",\n      \"pmids\": [\"28719828\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Hypothalamic CREB transcriptionally regulates expression of Pcsk2 in arcuate nucleus POMC neurons; shRNA-mediated inhibition of CREB reduced Pcsk2 expression, decreased alpha-MSH production, and increased diet-induced body mass gain with reduced energy expenditure.\",\n      \"method\": \"Single-cell RNA sequencing, PCR, immunoblot, ELISA, immunofluorescence, shRNA lentiviral knockdown in mouse hypothalamus\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function (CREB knockdown) linked to Pcsk2 expression and downstream alpha-MSH processing, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"35805082\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Replication of 5' terminally deleted coxsackievirus-B (CVB-TD) RNA forms in pancreatic beta cells decreases PCSK2 mRNA expression, leading to impaired insulin maturation and reduced insulin secretion.\",\n      \"method\": \"Mouse pancreatic infection model, viral RNA transfection into cultured rodent beta cells, qRT-PCR for PCSK2 mRNA, insulin plasma measurement, VP1 immunostaining co-localized with insulin content\",\n      \"journal\": \"Viruses\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct transfection experiment in beta cells demonstrating mechanism linking viral replication to PCSK2 mRNA reduction and impaired insulin processing, single lab\",\n      \"pmids\": [\"36560784\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Subtotal pancreatectomy increases PCSK2 expression in colonic enteroendocrine cells, shifting proglucagon processing toward glucagon production (rather than GLP-1/GLP-2), thus enabling the colon to act as an extra-pancreatic source of glucagon.\",\n      \"method\": \"Mouse subtotal pancreatectomy model, PCSK2 expression analysis in colon, measurement of glucagon and related peptide secretion\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo model with defined molecular mechanism (PCSK2 upregulation shifts substrate cleavage specificity), preprint, single lab\",\n      \"pmids\": [\"bio_10.1101_2024.12.23.630024\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"PCSK2 (PC2/SPC2) is a subtilisin-related serine protease residing in dense-core secretory granules of neuroendocrine cells that cleaves a broad range of prohormone substrates—including proglucagon, proinsulin, prosomatostatin, proneuropeptide Y, prodynorphin, and others—at dibasic sites to generate mature peptide hormones; its activity is modulated by the chaperone 7B2/Scg5, regulated transcriptionally by CREB in hypothalamic POMC neurons, and its loss in mice produces defective glucagon, somatostatin, and insulin processing with consequent metabolic and intestinal motility phenotypes.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PCSK2 (PC2/SPC2) is a subtilisin-related serine protease of neuroendocrine secretory vesicles that converts prohormones into mature bioactive peptides by cleaving at dibasic sites, and its activity is central to endocrine and metabolic regulation [#0, #1]. Genetic loss in mice severely impairs processing of proglucagon, prosomatostatin, and proinsulin in pancreatic alpha, delta, and beta cells, producing fasting hypoglycemia, islet cell hyperplasia, and glucagon deficiency [#0], and likewise disrupts processing of brain proneuropeptide Y and intestinal peptides (substance P, somatostatin, GLP-1, GLP-2, peptide YY) with delayed intestinal transit and blunted refeeding [#4]. Beyond these, PCSK2 uniquely generates dynorphin A-(1-8) from dynorphin A-(1-17) and processes secretogranin II [#2]. Substrate selection is context-dependent: in colonic enteroendocrine cells, increased PCSK2 expression shifts proglucagon cleavage toward glucagon rather than GLP-1/GLP-2 [#9]. PCSK2 abundance is set transcriptionally by CREB in arcuate POMC neurons, where it controls alpha-MSH production and energy balance [#7], and its catalytic activity is enhanced by the chaperone 7B2/Scg5 [#3]. A coding variant (R430W) broadens the enzyme's pH optimum, altering substrate processing across physiological pH [#6].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Establishing where the active enzyme resides addressed whether PCSK2 functions as a granule-localized processing protease and in what physical state.\",\n      \"evidence\": \"Subcellular fractionation of bovine pituitary and adrenal medulla secretory vesicles with immunoreactivity analysis\",\n      \"pmids\": [\"7595521\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not define catalytic substrates\", \"Functional significance of membrane vs soluble partitioning unresolved\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Genetic knockout established PCSK2 as physiologically required for prohormone maturation across multiple islet cell types, defining its core endocrine function and metabolic consequence.\",\n      \"evidence\": \"Exon 3 deletion knockout mouse, glucose tolerance testing, islet morphology\",\n      \"pmids\": [\"9192619\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct cleavage-site biochemistry not resolved in vivo\", \"Cause of alpha/delta cell hyperplasia not mechanistically defined\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Loss-of-function in a beta-cell line identified specific peptide substrates, sharpening which cleavages PCSK2 performs uniquely.\",\n      \"evidence\": \"Delta ribozyme silencing in betaTC-3 cells, dynorphin A-(1-8) measurement, differential proteomics\",\n      \"pmids\": [\"14734558\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Secretogranin II remains only a candidate substrate\", \"Single cell line and single lab\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Two studies addressed regulation and tissue distribution: the chaperone 7B2/Scg5 was shown to raise PCSK2 enzymatic activity, and co-expression mapping placed PCSK2 with intestinal peptide hormones.\",\n      \"evidence\": \"Mouse congenic strain analysis with enzymatic activity assays (Scg5); immunohistochemistry co-localization in duodenum/jejunum\",\n      \"pmids\": [\"18439298\", \"18706454\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Increased activity did not change alpha-MSH levels, leaving output regulation unclear\", \"IHC co-localization lacks direct processing validation\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"A knockout study extended PCSK2's role beyond endocrine pancreas to gut and brain peptide processing and to intestinal physiology.\",\n      \"evidence\": \"PCSK2 knockout mouse, intestinal transit assays, refeeding measurement, enzyme immunoassay, immunoblotting\",\n      \"pmids\": [\"21092739\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether processing defects act locally or systemically not separated\", \"Direct substrate cleavage not shown for all altered peptides\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Mutagenesis of a human coding variant tied enzyme biochemistry to potential altered substrate processing, addressing how sequence variation modulates PCSK2 function.\",\n      \"evidence\": \"In vitro transfection of human PC2 R430W constructs, enzymatic activity across pH range\",\n      \"pmids\": [\"28719828\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No in vivo or physiological consequence demonstrated\", \"Single in vitro assay\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Two studies defined upstream control of PCSK2 expression: CREB transcriptional regulation in POMC neurons coupling it to energy balance, and viral suppression of PCSK2 mRNA impairing insulin maturation.\",\n      \"evidence\": \"shRNA CREB knockdown with scRNA-seq/ELISA/immunofluorescence in hypothalamus; coxsackievirus-B-TD RNA transfection in beta cells with qRT-PCR and insulin measurement\",\n      \"pmids\": [\"35805082\", \"36560784\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct CREB binding to Pcsk2 promoter not shown\", \"Viral mechanism causing PCSK2 mRNA decrease not resolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"An extra-pancreatic context showed that altering PCSK2 levels redirects proglucagon processing toward glucagon, establishing that PCSK2 dosage tunes peptide product identity.\",\n      \"evidence\": \"Mouse subtotal pancreatectomy model with colonic PCSK2 expression and peptide secretion analysis (preprint)\",\n      \"pmids\": [\"bio_10.1101_2024.12.23.630024\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint, single lab\", \"Direct cleavage-product analysis not fully resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis of PCSK2 substrate specificity and how 7B2 chaperoning, pH, and expression level jointly determine which cleavage products dominate in a given cell remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of substrate selection\", \"Mechanism integrating chaperone, pH, and dosage control not unified\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 2, 4, 6]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 4]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 4]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"SCG5\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}